Anthony Gringeri, Senior VP Strategic Resources at ImmunoCellular Therapeutics, Ltd. (IMUC), bought 11,000 shares at $0.91 ($10K) on 2014-08-21, disclosed to the SEC on 2014-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.